SAB logo

SAB

A clinical-stage biopharmaceutical company with a novel immunotherapy platform that is developing fully-human anti-thymocyte immunoglobulin (hIgG) for delaying the onset or progression of type 1 diabetes (T1D)

51-200 employees

A clinical-stage biopharmaceutical company with a novel immunotherapy platform that is developing fully-human anti-thymocyte immunoglobulin (hIgG) for delaying the onset or progression of type 1 diabetes (T1D)

Frequently Asked Questions

How many employees does SAB have?

SAB has around 126 employees. As a Biotechnology Research company, they are actively growing their team with 0 open positions.

Why should I join SAB?

SAB is a leading Biotechnology Research company offering exciting career opportunities. With 0 open positions, now is a great time to join their growing team.

What does SAB do?

SAB is a Biotechnology Research company. A clinical-stage biopharmaceutical company with a novel immunotherapy platform that is developing fully-human anti-thymocyte immunoglobulin (hIgG) for delaying the onset or progression of type 1 diabe...